Mini Review
A descriptive overview of renal cell carcinoma and kidney transplantation
Author(s): Noah Evans*
Renal Cell Carcinoma (RCC) is more likely to develop in Kidney Transplant Recipients (KTRs) (RCC). The malignancy might appear at any point during the transplant process. RCC discovered during a transplant candidate's work-up requires therapy, and to reduce the chance of recurrence, a necessary monitoring period prior to transplantation is usually recommended. Candidates with small RCCs (less than 3 cm) who were discovered and removed by chance may skip the surveillance period. RCC in the donor organ, on the other hand, may not always limit use if the tumour is modest (between 2 cm and 4 cm) and resected with good margins prior to transplantation. 90% of RCCs are found in the native kidneys after transplantation, especially if acquired cystic kidney disease has occurred after continuous dialysis. After transplantation, no screening for RCC has been done discovered to be cost-effec.. Read More»
DOI:
10.37532/puljktd.22.5(1).9-10
+447915641605
